Discover
DRUG
Bright Minds Biosciences Inc.
80.11
1 x 79.19
1 x 80.18
bid
ask
-
0.68
0.84%
12:37 PM
timesize
| Ytd | 2.65% | |
| 1y | 106.74% |
79.18
day range
81.17
38.00
52 week range
123.75
| Open | 81.05 | Prev Close | 80.79 | Low | 79.18 | High | 81.17 | Mkt Cap | 784.44M |
| Vol | 103.81K | Avg Vol | 316.02K | EPS | -2.44 | P/E | -32.85 | Forward P/E | N/A |
| Beta | -5.27 | Short Ratio | 0.70 | Inst. Own | 44.28% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 71.12 | 200-d Avg | 76.06 | 1yr Est | 4.87 |
| Income Statement | |||
| Operating Expenses | 15.32M | ||
| Research and Development Expense | 13.05M | ||
| Selling, General and Administrative Expense | 1.15M | ||
| Operating Income | -15.32M | ||
| Net Income | -10.46M | ||
| Net Income Common Stock | -10.46M | ||
| Net Income Common Stock (USD) | -7.58M | ||
| Consolidated Income | -10.46M | ||
| Earnings per Basic Share | -1.09 | ||
| Earnings per Basic Share (USD) | -0.79 | ||
| Earnings per Diluted Share | -1.09 | ||
| Earning Before Interest & Taxes (EBIT) | -10.46M | ||
| Earning Before Interest & Taxes (USD) | -7.58M | ||
| Weighted Average Shares | 9.59M | ||
| Weighted Average Shares Diluted | 9.59M | ||
| Balance Sheet | |||
| Cash and Equivalents | 309.69M | ||
| Cash and Equivalents (USD) | 224.41M | ||
| Current Assets | 312.29M | ||
| Property, Plant & Equipment Net | 72.38K | ||
| Total Assets | 312.37M | ||
| Current Liabilities | 3.83M | ||
| Total Liabilities | 3.83M | ||
| Accumulated Retained Earnings (Deficit) | -64.60M | ||
| Shareholders Equity | 308.53M | ||
| Shareholders Equity (USD) | 223.57M | ||
| Assets Non-Current | 72.38K | ||
| Trade and Non-Trade Payables | 3.75M | ||
| Tax Assets | 160.31K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 19.80K | ||
| Net Cash Flow from Financing | 228.47M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 219.22M | ||
| Issuance (Purchase) of Equity Shares | -13.90M | ||
| Issuance (Repayment) of Debt Securities | -26.27K | ||
| Net Cash Flow from Operations | -9.25M | ||
| Effect of Exchange Rate Changes on Cash | 1.42M | ||
| Share Based Compensation | 1.20M | ||